Review
doi: 10.1016/S1470-2045(09)70185-8.
Epub 2009 Jul 15.
Sunitinib in renal-cell carcinoma: expanded indications
- PMID: 19615941
- DOI: 10.1016/S1470-2045(09)70185-8
Item in Clipboard
Review
Sunitinib in renal-cell carcinoma: expanded indications
Lancet Oncol.
2009 Aug.
No abstract available
Comment on
-
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.Lancet Oncol. 2009 Aug;10(8):757-63. doi: 10.1016/S1470-2045(09)70162-7. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615940 Clinical Trial.
Similar articles
-
Sunitinib for metastatic renal cell carcinoma.Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94. Future Oncol. 2010. PMID: 20919823 Review.
-
CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.Clin Cancer Res. 2007 Jul 1;13(13):3765-70. doi: 10.1158/1078-0432.CCR-06-2844. Clin Cancer Res. 2007. PMID: 17606705 Review. No abstract available.
-
New challenges in kidney cancer therapy: sunitinib.Ann Oncol. 2007 Jul;18 Suppl 9:ix83-6. doi: 10.1093/annonc/mdm298. Ann Oncol. 2007. PMID: 17631600 Review. No abstract available.
-
Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.Clin Genitourin Cancer. 2012 Dec;10(4):277-9. doi: 10.1016/j.clgc.2012.04.005. Epub 2012 Jun 1. Clin Genitourin Cancer. 2012. PMID: 22658385 No abstract available.
-
[Sunitinib versus interferon-alpha in metastatic renal-cell carcinoma].Prog Urol. 2007 Sep;17(5):996. doi: 10.1016/s1166-7087(07)92405-7. Prog Urol. 2007. PMID: 17969805 Clinical Trial. French. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
